1. Introduction {#sec0005}
===============

Hemostasis is defined as the maintenance of fluidity of the blood and the protection of the body against bleeding. This is achieved by a complex mechanism involving platelets, vessel wall, coagulation and the fibrinolytic system [@bib0005]. Serine proteases are crucial for hemostasis. They are involved in several pathways of the process leading to clot formation and fibrinolysis [@bib0010].

Cardiovascular diseases are one of the major cause of death worldwide [@bib0015]. New drugs with anticoagulant and fibrinogenolytic effect have been approved for use and represent an enormous market opportunity for pharmaceutical companies [@bib0020], [@bib0025]. The search for new drugs has led to the investigation of plant proteases and extracts as antiplatelet, anticoagulant or fibrinolytic compounds [@bib0030].

We have already reported the isolation and partial biochemical characterization of *St*STBc-3, a subtilisin-like protease from *Solanum tuberosum* leaves [@bib0035]. Data obtained demonstrate that *St*STBc-3 degrades all chains of human fibrinogen *in vitro* and inhibits platelet aggregation induced by collagen; therefore, *St*STBc-3 has potential to be used in therapeutics for cardiovascular diseases [@bib0040].

Several factors like pH, temperature and enzyme concentration affect enzymatic activities. In a previous work we carried out a preliminary study on the effect that these variables have on the fibrinogenolytic activity [@bib0040]. However, this approach did not take into account the possible mutual interactions between variables.

Response surface methodology (RSM) was successfully utilized for optimization of several enzymatic reactions [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065]. This technique involves an assortment of strategies to investigate ideal working conditions for a certain methodology. For quantitative variables RSM comprise fitting quadratic or linear functions of the independent variables to the response. Further actions are decided by characterizing of the model-generated surface [@bib0070]. The implementation of *rsm* package in R [@bib0075] facilitates classical response-surface methods. This type of analysis is described in Box et al., Khuri et al., Myers et al., Hunter et al., and Ryan et al. [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100].

The aim of this work was to optimize the *in vitro* fibrinogenolytic activity of *St*STBc-3, analyzing the effect of pH, temperature and enzyme concentration through RSM.

2. Material and methods {#sec0010}
=======================

2.1. Enzyme purification {#sec0015}
------------------------

The *St*SBTc-3 enzyme was purified following the method previously developed by Fernández et al. [@bib0035]. The protease was extracted infiltrating potato leaves with buffer (15 ml of Tween 20; 50 mM Tris--HCl (pH 8); 3.5% (w/v) NaCl; and 0.1% (v/v) *β*-mercaptoethanol) followed by centrifugation. *St*SBTc-3 was then purified from the washing fluid through ion-exchange chromatography. The eluted fraction with protease activity where purified again, through size exclusion chromatography to obtain the pure enzyme. The detailed protocol for purification and identification of this protease can be found elsewhere [@bib0040], [@bib0035].

2.2. Protein concentration assay {#sec0020}
--------------------------------

Protein concentration was determined by quantification with bicinchoninic acid [@bib0105] with a commercial kit (PanReac AppliChem). The calibration curve was constructed by quantification with bovine serum albumin. For the assays, 25 μl of sample was mixed with 200 μl of bicinchoninic acid solution supplemented with Cu^+2^ according to the manufacturer\'s specifications. The reaction was incubated for 30 min at 37 °C. The absorbance (540 nm) was measured in a microplate reader (BioTek ELx800).

2.3. Response determination (fibrinogenolytic activity) {#sec0025}
-------------------------------------------------------

Responses were evaluated measuring the fibrinogenolytic activity of *St*SBTc-3. In order to do that the method utilized by Pepe et al. [@bib0040] was used. Solutions containing 40 μg of human fibrinogen were incubated with *St*SBTc-3. Trichloroacetic acid (3% (v/v) final concentration) was added to the mixture to stop the reaction. The protein concentration of peptides remaining in solution after the precipitation was quantified using the protein concentration assay (Section [2.2](#sec0020){ref-type="sec"}). Enzymatic activity was defined as the amount of enzyme which increase absorbance in 0.001/min at 540 nm.

2.4. Design of experiments and data analysis {#sec0030}
--------------------------------------------

The *in vitro* fibrinogenolytic activity of *St*SBTc-3 was optimized through RSM. Assays were performed at different pH, temperatures and *St*STBc-3 concentrations according to [Table 2](#tbl0010){ref-type="table"}. Fibrinogenolytic activity was measured in order to select the optimum conditions of the enzyme (Section [2.3](#sec0025){ref-type="sec"}).

In this work a Box--Behnken design (BBD) was utilized to optimize the conditions throw RSM analysis. The design consist in 12 experiments corresponding to a 3 factor BBD plus 3 experiments in the middle of the predictors variables domain.

The 3 variables studied were temperature, pH and enzyme concentration. The levels assigned for the predictors are shown in [Table 1](#tbl0005){ref-type="table"} and were selected using previous data [@bib0040].Table 1Predictors variables and their values selected for the Box--Behnken design (BBD) for optimization of fibrinogenolytic activity of *St*SBTc-3.Table 1Independent variableSymbolLevelsUncodifiedCodified−101Enzyme concentration (μM)*X*~1~*x*~1~0.22.65.0pH*X*~2~*x*~2~6810Temperature (°C)*X*~3~*x*~3~203550

The variables *X*~*i*~ were coded as *x*~*i*~. The coded variables are defined according to Eq. [(1)](#eq0005){ref-type="disp-formula"} and they are dimensionless.$$x_{i} = \frac{X_{i} - X_{0}}{\Delta X_{i}}$$Δ*X*~*i*~ is the range for each predictor *X*~*i*~, *X*~0~ is the value of the real value at the central point, *X*~*i*~ is the real value of each independent variable and *x*~*i*~ is the corresponding coded value. In [Table 1](#tbl0005){ref-type="table"} are shown the predictors variables and the levels adopted for each one. The 15 runs were performed randomly to minimize bias. Two replications of each experiment were done and the average enzymatic activity was taken as the response, *Y*. The responses obtained are presented in [Table 2](#tbl0010){ref-type="table"}.Table 23 factors Box--Behnken design and responses obtained.Table 2No.*x*~1~*x*~2~*x*~3~*Y*1−1−100.122−1100.153−10−10.174−1010.14501−10.3560110.3770−1−10.2580−110.27910−10.45101010.75111−100.62121100.59130000.61140000.65150000.59

A quadratic function was fitted to obtain the model that describes the relationship between the response (*Y* -- fibrinogenolytic activity) and the 3 independent variables (coded). The equation below represent the model obtained:$$\begin{array}{lll}
Y & = & {b_{0} + b_{1}x_{1} + b_{2}x_{2} + b_{3}x_{3} + b_{11}x_{1}^{2} + b_{22}x_{2}^{2} + b_{33}x_{3}^{2}} \\
 & & {+ b_{12}(x_{1}x_{2}) + b_{13}(x_{1}x_{3}) + b_{23}(x_{2}x_{3})} \\
\end{array}$$where *Y* is the predicted response (predicted fibrinogenolytic activity), *x*~*i*~ are the coded independent variables, *b*~0~ the model constant, *b*~*i*~ the first order effect of *x*~*i*~, *b*~*ii*~ the quadratic effect of *x*~*i*~ and *b*~*ik*~ the interaction coefficient between *x*~*i*~ and *x*~*k*~.

We used the implementation of *rsm* package [@bib0070] in R [@bib0075] to perform the regression analysis of the experimental data, the construction of the model and the graphical representation of the isoresponse curves. The significance of the coefficients was assessed through ANOVA. The fitting quality of the model was tested through the coefficient of determination *R*^2^.

2.5. Verification and validation of the model {#sec0035}
---------------------------------------------

For verification of the model, *St*SBTc-3 fibrinogenolytic activity was measured under several conditions according to Section [2.3](#sec0025){ref-type="sec"}. The predicted data were compared with experimental measurements to assess the validity of the model.

3. Results and discussion {#sec0040}
=========================

3.1. Fitting the models {#sec0045}
-----------------------

We utilized RSM to perform a prediction model for optimize the *in vitro* fibrinogenolytic activity of the *Solanum tuberosum* serine protease (*St*SBTc-3). The experimental conditions and their responses from the BBD are presented in [Table 2](#tbl0010){ref-type="table"}.

The independent variables and the response were analyzed in order to obtain the coefficients of Eq. [(1)](#eq0005){ref-type="disp-formula"}. The values of these coefficients are presented in [Table 3](#tbl0015){ref-type="table"}.Table 3Regression coefficients obtained for the RSM generated model. Signif. codes: 0 \*\*\*; 0.001 \*\*; 0.01 \*; 0.05 .; 0.1. Multiple *R*-squared: 0.979, Adjusted *R*-squared: 0.9411. *F*-statistic: 25.87 on 9 and 5 DF, *p*-value: 0.001132.Table 3TermRegression coefficientStd. Error*t* value*p* value*b*~0~6.1667e^−1^3.0322e^−2^20.33705.317e^−6^\*\*\**b*~1~2.2875e^−1^1.8569e^−2^12.31926.240e^−5^\*\*\**b*~2~2.5000e^−2^1.8569e^−2^1.34640.235999*b*~3~3.8750e^−2^1.8569e^−2^2.08690.091263.*b*~12~−1.5000e^−2^2.6260e^−2^−0.57120.592572*b*~13~8.2500e^−2^2.6260e^−2^3.14170.025618\**b*~23~−6.3144e^−18^2.6260e^−2^0.00001.000000*b*~11~−8.9583e^−2^2.7332e^−2^−3.27760.022013\**b*~22~−1.5708e^−1^2.7332e^−2^−5.74720.002236\*\**b*~33~−1.4958e^−1^2.7332e^−2^−5.47280.002775\*\*

The regression equation that predicts the fibrinogenolytic activity (*Y*) is presented below:$$\begin{array}{lll}
Y & = & {6.17e^{- 1} + 2.29e^{- 1}x_{1} + 2.50e^{- 2}x_{2} + 3.88e^{- 2}x_{3} - 8.96e^{- 2}x_{1}^{2}} \\
 & & {- 1.57e^{- 1}x_{2}^{2} - 1.50e^{- 1}x_{3}^{2} - 1.50e^{- 2}(x_{1}x_{2}) + 8.25e^{- 2}(x_{1}x_{3}) - 6.31e^{- 18}(x_{2}x_{3})} \\
\end{array}$$

The plot of experimental responses vs those predicted from the model indicated a good fit ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Correlation of calculated response with experimental fibrinogenolytic activity.Fig. 1

The results of analysis of variance (ANOVA) for the BBD are presented in [Table 4](#tbl0020){ref-type="table"}.Table 4Analysis of Variance Table for the RSM generated model. Multiple *R*-squared: 0.979, Adjusted *R*-squared: 0.9411. *F*-statistic: 25.87 on 9 and 5 DF, *p*-value: 0.001132. FO: first order; TWI: two-way interaction; PQ: pure quadratic.Table 4DfSumSqMean Sq*F*-value*Pr*(\> *F*)FO(*x*~1~, *x*~2~, *x*~3~)30.435630.14520852.64350.0003324TWI(*x*~1~, *x*~2~, *x*~3~)30.028120.0093753.39880.1105318PQ(*x*~1~, *x*~2~, *x*~3~)30.178430.05947721.56270.0027360Residuals50.013790.002758Lack of fit30.011920.0039754.25890.1959881Pure error20.001870.000933

Results obtained from the analysis of variance ([Table 4](#tbl0020){ref-type="table"}) show that the pure quadratic (PQ) second-order term contribution is significant to the model, so the second order analysis is relevant. The two-way interaction (TWI) was not significant. Similar results were found for other proteases [@bib0110], [@bib0065]. The coefficient of determination (*R*^2^) for the model fitted is 0.94 ([Table 4](#tbl0020){ref-type="table"}). This implies that 94% of the variations could be explained by the fitted model.

3.2. Effect of independent variables on the response {#sec0050}
----------------------------------------------------

The effects of enzyme concentration, pH and temperature were analyzed by RSM and the regression coefficients of the second order function are shown in [Table 3](#tbl0015){ref-type="table"}. The contribution of the 3 variables studied was relevant to explain the responses obtained. Linear and quadratic contribution to the model were significant to explain the variance of the model, while two-way interactions were non significant ([Table 4](#tbl0020){ref-type="table"}).

The contribution of the linear term for enzyme concentration was significant (*p* \< 0.0001). Also, were significant the quadratic contribution for pH and temperature ([Table 3](#tbl0015){ref-type="table"}).

The linear contribution for enzyme concentration (2.29e^−1^) is one magnitude order higher than the quadratic contribution (−8.96e^−2^), implying that the relationship between this variable and the response is approximately linear. These results agree with previous data obtained [@bib0040].

The quadratic coefficients for pH and temperature were higher than the linear ones ([Table 3](#tbl0015){ref-type="table"}) implying the quadratic responses were relevant in these cases. The relation between variables and the response are shown in contour plots ([Fig. 2](#fig0010){ref-type="fig"}) and response surfaces ([Fig. 3](#fig0015){ref-type="fig"}).Fig. 2Contour maps showing the response for two variables at a time. The variable not shown in each plot was kept at the stationary point. (A) Temperature (°C) vs pH, slice at enzyme concentration of 5 μM; (B) enzyme concentration (μM) vs pH, slice at 43.27 °C; (C) enzyme concentration (μM) vs temperature (°C), slice at pH 8.Fig. 2Fig. 3Surfaces showing the response for two variables at a time. The variable not shown in each plot was kept at the stationary point. (A) Temperature (°C) vs pH, slice at enzyme concentration of 5 μM; (B) enzyme concentration (μM) vs pH, slice at 43.27 °C; (C) enzyme concentration (μM) vs temperature (°C), slice at pH 8.Fig. 3

Enzyme concentration shows a linear effect on the response, implying the fibrinogenolytic activity increase with the increment of *St*SBTc-3 concentration in a dose-dependent manner.

However, pH and temperature showed a quadratic effect on the response. Activity increase to about pH 8 and 40 °C and declines with further increase in both independent variables ([Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}).

3.3. Optimum conditions and verification of the model {#sec0055}
-----------------------------------------------------

Optimum conditions for testing fibrinogenolytic activity of *St*STBc-3 were obtained from the model Eq. [(3)](#eq0015){ref-type="disp-formula"}. Under optimum conditions of enzyme concentration 5 μM, pH 8 and 43 °C, a maximum fibrinogenolytic activity of 0.62 was predicted. The model was further tested comparing the optimum response value with independent experiments performed in the calculated optimum conditions. There were no statistically significant differences between experimental fibrinogenolytic activity (0.55) and the predicted value (0.62).

In previous work a preliminary characterization of *St*STBc-3 varying one variable at a time was carried out without taken into account mutual interactions. An optimum pH (8) and temperature (40 °C) was found [@bib0040]. The results obtained in the present work agree with these data. This fact may be explained due to the non-significant mutual interaction of the variables. Each variable contribute independently to the response.

The optimum pH and temperature are in the same range as the ones obtained for other plant serine proteases [@bib0115], [@bib0120]. This could imply that the fibrinogenolytic activity on human fibrinogen is due to the serine active site.

4. Conclusions {#sec0060}
==============

Enzyme concentration, pH and temperature conditions were optimized with RSM in order to enhance the *in vitro* fibrinogenolytic activity of *St*SBTc-3.

From the RSM model optimum conditions for pH and temperature were 8 and 43 °C, respectively. The effect of enzyme concentration on the response was linear, showing higher effect at higher concentrations. The activity corresponding to the optimum conditions were further confirmed by verification experiments. There are not significant difference between the experimental results obtained for fibrinogenolytic activity under optimum conditions and the predicted from the model.

This approach is better than the one used before because the Box--Behnken design utilized here reduce the number of experiments required to obtain statistically significant information. The RSM analysis implemented through the *rsm* package in R is a great tool to efficiently obtain the information required. It allowed us to obtain the optimum conditions for *St*STBc-3 fibrinogenolytic activity. The model also predicts the response accurately in a wider variable\'s domain. This is useful for biotechnological purposes. Our future goal is to attach this enzyme onto a polymeric surface, and being able to predict the response will help us to predict the activity of the enzyme during the steps of the derivatization process. Trough the surface plot analysis, we can determine the area of the variable\'s domain which correspond to higher activities. This allows as to predict the response under physiological conditions. From the model obtained, the activity under physiological conditions is still high enough to be considered for biomedical applications.
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